Certain Microbiome Germs Might Trigger Lupus Flare-Ups
TUESDAY, June 27, 2023 (HealthDay News) — Flare-ups of the autoimmune condition lupus may be caused by growth of a particular gut bacteria, researchers say. This knowledge could potentially lead to new and more successful treatments to prevent these …
Learn MoreCombo Therapy Could Treat Oral Melanomas in Dogs
TUESDAY, June 27, 2023 (HealthDay News) — Could a treatment combo that improves the odds against melanoma for humans work in dogs?Yes, claims a new study that found radiotherapy followed by immunotherapy extended survival in canine melanoma patients….
Learn MoreTime-Restricted Eating More Effective for Weight Loss Than Control
MONDAY, June 26, 2023 (HealthDay News) — Time-restricted eating (TRE) is more effective for weight loss than control, but is no more effective than calorie restriction (CR), according to a study published online June 27 in the Annals of Internal Medi…
Learn MoreApril 2022 to March 2023 Saw Rise in E-Cigarette Poisoning Exposures
MONDAY, June 26, 2023 (HealthDay News) — During April 2022 to March 2023, the number of reported U.S. electronic cigarette (e-cigarette) poisoning exposure cases increased, according to research published in the June 23 issue of the U.S. Centers for…
Learn MoreNew U.S. Report on COVID-19 Origins Refutes Wuhan Lab Leak Theory
MONDAY, June 26, 2023 (HealthDay News) — U.S. intelligence officials have released a report that rejects some points made by those who say the new coronavirus leaked from a lab in Wuhan, China.
The report was issued Friday in response to a Congressio…
Learn MoreParents, Caregivers Generally Support Mental Health Screening
MONDAY, June 26, 2023 (HealthDay News) — Most parents and caregivers support mental health screening for their child, according to a study published online June 20 in JAMA Network Open.Mirelle Kass, from the Child Mind Institute in New York City, and…
Learn MoreFDA Approves Talzenna for Metastatic, Castration-Resistant Prostate Cancer
MONDAY, June 26, 2023 (HealthDay News) — The U.S. Food and Drug Administration has approved Talzenna (talazoparib) with enzalutamide for homologous recombination repair (HRR) gene-mutated metastatic castration-resistant prostate cancer (mCRPC).The ap…
Learn More